Drug Shortage Report for CHOLESTYRAMINE-ODAN
| Report ID | 135762 |
| Drug Identification Number | 02455609 |
| Brand name | CHOLESTYRAMINE-ODAN |
| Common or Proper name | Cholestyramine for Oral Suspension, USP |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | CHOLESTYRAMINE RESIN |
| Strength(s) | 4G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 30 x 4g |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-03-17 |
| Actual start date | 2021-03-17 |
| Estimated end date | 2021-05-03 |
| Actual end date | 2021-04-27 |
| Shortage status | Resolved |
| Updated date | 2021-04-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-04-28 | English | Compare |
| v5 | 2021-04-27 | French | Compare |
| v4 | 2021-04-27 | English | Compare |
| v3 | 2021-03-18 | English | Compare |
| v2 | 2021-03-16 | French | Compare |
| v1 | 2021-03-16 | English | Compare |
Showing 1 to 6 of 6